Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: A retrospective multicentre study on 33 patients.
British Journal of Haematology.
Times cited: 55
Repeated courses of Rituximab in chronic ITP: Three different regimens.
American Journal of Hematology.
Times cited: 37